A therapeutic trial of gangliosides and thymosin in the wobbler mouse model of motor neuron disease

Dale J. Lange, Paul F. Good, Walter G Bradley

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Mixed bovine gangliosides have been reported to enhance neuronal regeneration and sprouting. The Wobbler mouse model of motor neuron disease was used to test the clinical effects of long-term ganglioside administration on the course of the disease. Mixed gangliosides were injected subcutaneously into a group of 5 Wobbler mice and compared to a control group of 5 Wobbler mice which received saline. Because of several reports implicating involvement of the immune system in ALS, a 3rd group of 5 Wobbler mice received thymosin. All mice were 4 weeks old at commencement of injections. The 3 groups were examined weekly and graded with respect to front leg power, ability to climb a vertical grating, and walking posture. After 4 months of treatment, no significant difference between either experimental group and the controls was found.

Original languageEnglish
Pages (from-to)211-216
Number of pages6
JournalJournal of the Neurological Sciences
Volume61
Issue number2
DOIs
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Thymosin
Motor Neuron Disease
Gangliosides
Therapeutics
Control Groups
Posture
Walking
Regeneration
Immune System
Leg
Injections

Keywords

  • Gangliosides
  • Motor neuron disease
  • Thymosin
  • Wobbler mouse

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Neuroscience(all)
  • Developmental Neuroscience
  • Neurology

Cite this

A therapeutic trial of gangliosides and thymosin in the wobbler mouse model of motor neuron disease. / Lange, Dale J.; Good, Paul F.; Bradley, Walter G.

In: Journal of the Neurological Sciences, Vol. 61, No. 2, 01.01.1983, p. 211-216.

Research output: Contribution to journalArticle

@article{1b3ed25a75974b1185458b713987c90b,
title = "A therapeutic trial of gangliosides and thymosin in the wobbler mouse model of motor neuron disease",
abstract = "Mixed bovine gangliosides have been reported to enhance neuronal regeneration and sprouting. The Wobbler mouse model of motor neuron disease was used to test the clinical effects of long-term ganglioside administration on the course of the disease. Mixed gangliosides were injected subcutaneously into a group of 5 Wobbler mice and compared to a control group of 5 Wobbler mice which received saline. Because of several reports implicating involvement of the immune system in ALS, a 3rd group of 5 Wobbler mice received thymosin. All mice were 4 weeks old at commencement of injections. The 3 groups were examined weekly and graded with respect to front leg power, ability to climb a vertical grating, and walking posture. After 4 months of treatment, no significant difference between either experimental group and the controls was found.",
keywords = "Gangliosides, Motor neuron disease, Thymosin, Wobbler mouse",
author = "Lange, {Dale J.} and Good, {Paul F.} and Bradley, {Walter G}",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0022-510X(83)90006-0",
language = "English",
volume = "61",
pages = "211--216",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A therapeutic trial of gangliosides and thymosin in the wobbler mouse model of motor neuron disease

AU - Lange, Dale J.

AU - Good, Paul F.

AU - Bradley, Walter G

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Mixed bovine gangliosides have been reported to enhance neuronal regeneration and sprouting. The Wobbler mouse model of motor neuron disease was used to test the clinical effects of long-term ganglioside administration on the course of the disease. Mixed gangliosides were injected subcutaneously into a group of 5 Wobbler mice and compared to a control group of 5 Wobbler mice which received saline. Because of several reports implicating involvement of the immune system in ALS, a 3rd group of 5 Wobbler mice received thymosin. All mice were 4 weeks old at commencement of injections. The 3 groups were examined weekly and graded with respect to front leg power, ability to climb a vertical grating, and walking posture. After 4 months of treatment, no significant difference between either experimental group and the controls was found.

AB - Mixed bovine gangliosides have been reported to enhance neuronal regeneration and sprouting. The Wobbler mouse model of motor neuron disease was used to test the clinical effects of long-term ganglioside administration on the course of the disease. Mixed gangliosides were injected subcutaneously into a group of 5 Wobbler mice and compared to a control group of 5 Wobbler mice which received saline. Because of several reports implicating involvement of the immune system in ALS, a 3rd group of 5 Wobbler mice received thymosin. All mice were 4 weeks old at commencement of injections. The 3 groups were examined weekly and graded with respect to front leg power, ability to climb a vertical grating, and walking posture. After 4 months of treatment, no significant difference between either experimental group and the controls was found.

KW - Gangliosides

KW - Motor neuron disease

KW - Thymosin

KW - Wobbler mouse

UR - http://www.scopus.com/inward/record.url?scp=0020610485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020610485&partnerID=8YFLogxK

U2 - 10.1016/0022-510X(83)90006-0

DO - 10.1016/0022-510X(83)90006-0

M3 - Article

C2 - 6644326

AN - SCOPUS:0020610485

VL - 61

SP - 211

EP - 216

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -